NCT03090165
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03090165
Title Ribociclib and Bicalutamide in AR+ TNBC
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kari Wisinski
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois Cancer Center Chicago Illinois 60612 United States Details
Michigan State University Lansing Michigan 48910 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
University of Rochester Medical Center Rochester New York 14642 United States Details
Penn State Cancer Institute Hershey Pennsylvania 17033 United States Details
University of Wisconsin Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field